U.S.: FTC, animal health co reach agreement on distribution exclusivity deals
IDEXX Laboratories Inc has signed a Consent Agreement with the Federal Trade Commission to settle an investigation into whether the diagnostics and information technology solutions company had hampered competition. The company specializes in animal health as well as water and milk supply quality. Under terms of the agreement, IDEXX can no longer have exclusive distribution contracts with three veterinary companies at once. The three companies named are MWI Veterinary Supply, Inc., Butler Schein Animal Health and Webster Veterinary. The agreement says that IDEXX can maintain those exclusivity agreements with two at once, however. IDEXX has not admitted to any legal misdoings, and its CEO and chairman Jonathan Ayers said in a statement that the agreement is a “milestone” in resolving the investigation.
Featured News
President Trump’s Media Investments Stir Ethics Questions After Netflix–Warner Bros. Deal
Jan 19, 2026 by
CPI
Elon Musk Seeks Billions in Damages From OpenAI and Microsoft as Legal Fight Heads to Trial
Jan 19, 2026 by
CPI
Italy’s Leonardo Chairman Floats Possible Merger With Fincantieri
Jan 19, 2026 by
CPI
Spanish Competition Authority Clears Naver’s Takeover of Wallapop
Jan 19, 2026 by
CPI
As Companies Move From AI Testing to Implementation, Compliance Takes Center Stage
Jan 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi